Items 101 ~ 88 of 2176, Page 11 of 272
Late-Breaking Data Presentations at ACC 2019 Highlight Abbott''s Leading Cardiovascular Portfolio
Five late-breaking data presentations at ACC 2019 showcase the breadth and depth of Abbott's cardiovascular portfolio / New late-breaking data highlig...
Merck Begins Tender Offer to Acquire Immune Design
Abbott''s Latest Diagnostics Technology, Alinity, Selected by Regional Medical Laboratory, Inc. to Deliver Benefits to Hospitals and Patients
Regional Medical Laboratory, Inc., which is part of the Ascension network, partners with Abbott, the global health leader, to advance lab capabilities...
Merck Prices $5.0 Billion Debt Offering
European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) for Six-Week Dosing Schedule Across All Current Monotherapy Indications
In the EU, KEYTRUDA as monotherapy is currently approved for eight indications across five tumor types
Medtronic Announces Pricing of €7.0 Billion of Senior Notes
Medtronic Announces the Upsizing of its Maximum Tender Offers for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
Medtronic Statement Regarding IN.PACT Paclitaxel Safety Analysis Correction Letter in The Journal of the American College of Cardiology